TD Asset Management Inc

Position in VERA — Vera Therapeutics, Inc.

CIK 1056053 Toronto, A6

Position in VERA

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$5,495,483

-$2,308,895 QoQ

Shares Held

128,070

-34.0% QoQ

Ownership

0.178%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#61

of 217 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. VERA ranks #42 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,495,483	128,070	-34.0%	Shares	Sole	2026-08-04
2026-03-31	$7,804,378	193,994	-40.4%	Shares	Sole	2026-05-11
2025-12-31	$16,486,560	325,564	+54.7%	Shares	Sole	2026-02-10
2025-09-30	$6,116,374	210,474	+5.1%	Shares	Sole	2025-11-10
2025-06-30	$4,718,455	200,274	-20.6%	Shares	Sole	2025-07-28
2025-03-31	$6,056,979	252,164	+9.4%	Shares	Sole	2025-05-07
2024-12-31	$9,750,297	230,558	+19.5%	Shares	Sole	2025-02-11
2024-09-30	$8,525,914	192,894	+25.0%	Shares	Sole	2024-11-01
2024-06-30	$5,583,948	154,338	+18.4%	Shares	Sole	2024-08-02
2024-03-31	$5,620,174	130,338	—	Shares	Sole	2024-05-08
No filing history on record for this holder in this stock.